chrisvoncsefalvay/vaers-outcomes huggingface dataset:
veins are popping out; Her fingers are all getting twisted to the side; Hurting; Fatigue; her body is deteriorating; She cant sleep; her bones, her hands they are becoming deformed.; her bones, her hands they are becoming deformed.; all of a sudden is down; This is a spontaneous report via contactable consumer. A female patient (reporters mother) of an unspecified age received first and second doses of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) as DOSE 1, SINGLE and DOSE 2, SINGLE both on an unspecified date and unspecified route of administration for COVID-19 immunisation. The patients medical history and concomitant medication were not reported. On an unspecified date, patient had veins are popping out, her fingers are all getting twisted to the side, hurting, fatigue, her body is deteriorating, she cant sleep, her bones, her hands they are becoming deformed, all of a sudden is down. It was reported that patient was 100% healthy no health conditions had her body deteriorating, veins popping out, all fingers getting twisted to the side, severe fatigue, with her bones and hands becoming deformed and suddenly felt down after receiving both vaccines. Otherwise, she was previously out going, beautiful, radiant, walked into the room and feel like the sun is shining with her smile. The outcome of events was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Information has been received from a licensed practical nurse concerning a 10 year old patient of unknown gender. On 01-OCT-2014, the patient was vaccinated with a second dose of VAQTA (lot # K007791 expiration date 22-AUG-2016) (dose and routed not reported). The vaccine was reported to have temperature excursions from 10-SEP-2014 to 12-SEP-2014. No adverse reports. This is one of several reports from the same source. Additional information is not expected because all follow ups requested to complete the case were received.
not feeling well, cough, congested, achy and possible symptoms of covid 19; This is a spontaneous report received from a contactable consumer or other non health care professional (patient's mother). A 19-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number and Expiration date not reported), via an unspecified route of administration in an unspecified anatomical location on 13Mar2021 (at the age of 19-year-old), as a single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not provided. On 14Mar2021 the patient started not feeling well, cough, congested, achy and possible symptoms of COVID-19. The patient underwent lab tests and procedures which included: SARS-CoV-2 test: positive on 16Mar2021. The reporter was concerned about whether the patient be able to get the second dose of vaccine. The outcome of events was not provided.  Product Complaint: There is no product complaint associated with this case.  Information about batch/Lot number has been requested.
Acute onset of bronchospasm within 24 hours of H1N1 flumist.  10/28/09 and 10/29/9 Medical records records received for DOS 10/23. C/O Trouble breathing.  Child developed SOB /wheeze. On PE  mild exp wheeze bilat  1 day s/p vaccine. Fever 99.3. O2 sat 89% (at school). Nebulized x3 at school. Discharged to home. Routine care. RTC as needed.
Within 2 hours of vaccine I struggled to breathe. My chest felt extremely heavy as if I was having an asthma attack that would not go away. I was using my inhaler every 2 hours for 9 days straight and my nebulizer any time I would lay down for extended periods of time. I was unable to catch my breathe even after short walks from one side of the house to another. The first 72 hours were the worse and my dr would not see me stating "I was showing covid symptoms" even after I explained I had the vaccine recently. She wanted me to go get tested prior to coming to office but I was unable to walk/drive to be able to get this task completed.  The second dose had the same reaction except this time it only took 5 days not 9 to recover. I do get very heavy chested easier then prior to the vaccine and am waiting on further doctors evaluations and further testing.
Shingles. A dermatomal, vesicular, mildly painful rash broke out on the torso. Onset approximately 4-5 days following treatment. Symptoms lasted 2 weeks, subsided with medication. Scars remain where the rash was present.
Pt recvd DTP/OPV/HIB; Approx 3 mins later, mom started screaming pt can't see; Pt picked up by RN, carried to room pupils dilated, pt sobbing resps reg; cool, color pale; pupils returned to normal w/in approx 1/2 min; dx w/syncope;
Rash around lips, aches and pains all over approx 1-2 hrs post vaccine. Dr prescribed BENADRYL and MEDROL Dose Pak.
Had a stroke Saturday morning- Oct. 22nd 2022  Ischemic Stroke on the left side.  It effected his right side of his face.  He has slurred speech and his face was drooping down.  He was unsure what time it happened but he felt it was when he was sleeping.  Took him to the ER around 10am.   He was admitted for a stroke.  Discharged from the hospital - Monday - 24th   Local Hospital
C/p worsening redness and swelling of left arm.  Patient related recent vaccination in site but also history of multiple lab draws from the same arm with redness/swelling beginning at lab draw site but extending to entire are.  Began 5/29/13 pm (day of vaccine); went to PCP on 5/30/13 and place on po abx (Omnicef); seen in ED on 5/31/13- admitted to the hospital; IV abx given on admission plus US to r/o DVT which was negative.
Patient had 3 episodes of dizziness @ 9-9:30 am, 11:30-12 pm and 6:30 pm. 61 y/o female played tennis at 9 am, tried some bread, minutes later, felt dizziness, (didn't feel like it was vertigo); felt better, and played tennis, at 1130 ate bread, and again felt dizzy, sat down, then felt disoriented, felt tired, unsure if passed out, went upstairs and showered, went out and ran errands, 630 pm felt dizziness, called husband and found to be seated on chair and hand shaking for 5 sec, fell asleep on sofa, couldn't sleep well; did wake up with headache and resolved.
Breasts were swollen; Stomach also felt as if she was pre-menstrual; Swelling of the lymph nodes under her both arms; This spontaneous case was reported by an other health care professional and describes the occurrence of BREAST SWELLING (Breasts were swollen), ABDOMINAL DISCOMFORT (Stomach also felt as if she was pre-menstrual) and LYMPHADENOPATHY (Swelling of the lymph nodes under her both arms) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 031L20A) for COVID-19 vaccination.     It was reported that patient had not tested positive for COVID or diagnosis.  The patient's past medical history included Menopause (menopause at 62 years old). Concurrent medical conditions included Lactose intolerant, Drug allergy (Allergy to Meclizine), Sarcoidosis (Sarcoidosis which was remission) and Hot flushes. Concomitant products included ESTROGENS CONJUGATED (PREMARIN) for Prophylaxis, PROGESTERONE for an unknown indication.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BREAST SWELLING (Breasts were swollen), ABDOMINAL DISCOMFORT (Stomach also felt as if she was pre-menstrual) and LYMPHADENOPATHY (Swelling of the lymph nodes under her both arms). At the time of the report, BREAST SWELLING (Breasts were swollen) and ABDOMINAL DISCOMFORT (Stomach also felt as if she was pre-menstrual) outcome was unknown and LYMPHADENOPATHY (Swelling of the lymph nodes under her both arms) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Gynaecological examination: normal (normal) Normal-was okay.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products included ESTROGENS CONJUGATED (PREMARIN) for Hot flushes.  Patient went to her OB-Gynaecologist who did an internal examination and informed her that she was okay.  Treatment information was not provided.   This case was linked to MOD-2022-566478 (Patient Link).
symptoms less pronounced, but itching in her feet/itching in her lower legs/itching in her chest/inching in her breast/very little itching in her back; This spontaneous case was reported by a nurse and describes the occurrence of PRURITUS (symptoms less pronounced, but itching in her feet/itching in her lower legs/itching in her chest/inching in her breast/very little itching in her back) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049L21A and 033H21A) for COVID-19 vaccination.     Patient did not have any allergies to medications, food and other products. Patient did not have COVID + test or diagnosis. Patient did not have any acute and chronic illnesses at the time of vaccination. Patient did not receive any other vaccines within 1 month prior to Moderna COVID-19 vaccine.    On 09-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Dec-2021, the patient experienced PRURITUS (symptoms less pronounced, but itching in her feet/itching in her lower legs/itching in her chest/inching in her breast/very little itching in her back). At the time of the report, PRURITUS (symptoms less pronounced, but itching in her feet/itching in her lower legs/itching in her chest/inching in her breast/very little itching in her back) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that patient was not under any concomitant or regular medication.  After the 1st and 2nd booster, the symptoms were less pronounced but the skin in the feet, lower legs, chest, breast and very little in the back was itching. This symptom was still ongoing but not as drastic as in the beginning, and patent had to wash the skin constantly with dove soap and water. No treatment had been given.  It was also reported that the symptoms were improved with residual effects.  The event did not cause patient to seek medical care(office visit, Urgent care, ER, hospitalized).  Patient had not experienced any similar event in the past.   This case was linked to MOD-2022-636336 (Patient Link).
This case was reported by a other health professional via sales rep and described the occurrence of pain in arm in a 59-year-old male patient who received SHINGRIX. On 17th April 2018, the patient received the 1st dose of SHINGRIX .5 ml. In April 2018, less than a month after receiving SHINGRIX, the patient experienced pain in arm and weight bearing difficulty. On an unknown date, the outcome of the pain in arm was recovered/resolved and the outcome of the weight bearing difficulty was unknown. It was unknown if the reporter considered the pain in arm and weight bearing difficulty to be related to SHINGRIX. Additional information was reported as follows: This case was reported by patient's wife. The patient was immunized with SHINGRIX on his right deltoid at his personal family doctor. The patient stated that, the shot was very painful and worst than anything else in the world. He stated that, for a week after receiving vaccination with SHINGRIX, he had difficulty lifting any weights at the gym, because it was hard to lift anything due to arm pain. The patient did not seek any medical attention and was fully recovered. The reporter had not agreed to follow-up with GlaxoSmithKline.
Sore arm; tired for a day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and FATIGUE (tired for a day) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (tired for a day). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse reaction, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm) and FATIGUE (tired for a day) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.   This case was linked to MOD-2021-392275, MOD-2021-392282 (Patient Link).
Headache & Myalgia Narrative: Headache, myalgia; 12/31/2020 & 1/15/21 Covid test (-)
This spontaneous report as received from a medical assistant refers to a 11 year old patient of unknown gender. On 05-NOV-2014 the patient was vaccinated with an expired dose of M-M-R II 0.5 ml, subcutaneously in the right arm (lot # H018948, expiration date: 18-OCT-2014). No adverse effects noted. This is one of the reports from the same source. Additional information has been requested.
Severe / acute pain in arm where pneumococcal polysaccharide was administered.  Pain was from top of shoulder to elbow.  Could not put any pressure on area due to pain.  On 9/28 acute pain still in back bicep.
Patient developed redness around the injection site. Physician examined patient and redness resolved within 15 minutes.
This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 29-Dec-2022 and administered vaccine on 16-Feb-2023) and NO ADVERSE EVENT (No adverse event) in a 74-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 043H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 16-Feb-2023, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 16-Feb-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date). On an unknown date,      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 29-Dec-2022 and administered vaccine on 16-Feb-2023).     No treatment drug details was reported.
5/24 20y.o. G1P0 at 41w1d. Pt not feeling any contractions or cramping. Denies vaginal leaking or bleeding. 5/25 SVD of baby.
migraines; This is a spontaneous report received from contactable reporter(s) (Nurse), Program ID: (054550). The reporter is the patient.  A 52-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MIGRAINE (non-serious), outcome "not recovered", described as "migraines".  Additional information: It was reported that the patient had migraines that started after a covid-19 vaccine dose. She didn't specify how long she had migraines. The adverse event was non-serious and the reporter considered the event was not caused by suspect product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Began to get severe chills about 9:30 PM, the same evening I received the vaccine.  Felt flu-like affects.  Went to bed with heavy layers of clothing and woke up at  @ 2 am with fever and tachycardia -heart rate @ 130 bpm.  Took a cold shower and went to bed sitting up with 2 pillow supporting me.  The tachycardia persisted until I finally fell back asleep. Woke up in the morning perfectly fine.
Fever Started day after nasal Swine vaccine lasted for 3 days 103.5 temp, diarrhea twice a day lasted first 2 days, sore throat lasted x 2 days, headache and other flu symptoms also. Cough lasted 6 days, worse the last 3 days cough , cough , cough, Chest was hurting on day 5 and 6 due to cough.  Went to urgent care on day 6 and had xray come back normal. and RX for oraphed was given. ...
Migraine 8 Hours, headache lasting 24 hrs, body aches 24 hrs, fatigue 48hours, nauseous 24 hrs, eye pain 24 hours, stiffness 24 hrs,
pt recv 1st vax; became cranky & had cramping sx;exp loss of appetite;31oct94,2nd dose adm & on same day, sx recurred; subsequently recovered;
9 hours after vaccine, sudden onset of fever, chills, headache, body ache, fatigue, soreness at site, swollen glands under arm and at collar bone.  These lasted about 24 hours and had mostly subsided 48 hours after vaccine.
Since receiving the vaccine it "went down on its own and its staying down".; This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 09Jan2021 at single dose for covid-19 immunization.  Medical history included diabetes from an unknown date. The patient's concomitant medications were not reported. The patient has diabetes and typically her "sugar runs high" but since receiving the vaccine, within a few days of having the shot, sugar went down all on its own, and its staying down. The patient wanted to document her experience as a positive effect to the vaccine, as she has not made any other lifestyle changes. The outcome of the event was unknown.  No follow up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Severe headache (day after), chills (night of), fatigue (day after), chest pain when taking deep breaths (2 days later)
nause and wanted to vomit; could not walk; collapsed.; lost taste and smell; lost taste and smell; tired; sore joints; Injection site bruise 2 weeks; freezing cold; dizzy; administration_date=26Aug2021 dose_number=3; administration_date=26Aug2021 dose_number=3; This is a spontaneous report from a contactable consumer (patient). A 70-year-old non pregnant female patient received BNT162b2 (COVID-19 VACCINE; Lot Number: EW0179), via an unspecified route of administration, administered in left arm on 26Aug2021 at 13:30 (at the age of 70 years old) as a DOSE 3 (BOOSTER), SINGLE DOSE for COVID-19 immunisation. Medical history included Multiple myeloma from an unspecified date and unknown if ongoing. The patient has known allergies from an unspecified date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient took Zometa infusion, five days after she took the vaccine shot. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received first dose of BNT162b2 (COVID-19 VACCINE; Lot Number: EL9266) on 24Feb2021 at 16:00 in the right arm via an unspecified route of administration for COVID-19 immunisation. The patient received second dose of BNT162b2 (COVID-19 VACCINE; Lot Number: ER8727) on 19Mar2021 at 13:45 in the right arm via an unspecified route of administration for COVID-19 immunisation. On 31 Aug2021 at 14:45 the patient experienced First lost taste and smell, second was tired and had sore joints and Injection site bruise 2 weeks, after third shot the patient experienced tired joints sore, woke freezing cold, dizzy, nausea and wanted to vomit at 03:00. The patient got up but could not walk and collapsed. She was unable to get up. The treatment for the events was unknown reported. The outcome of the events was recovering.  Follow-up attempts are completed. No further information is expected.
Pt cried unconsolably for greater than 11 hrs. He would only take small amts of formula, then would cry. He dozed off several times and moaned in his sleep (slept 1 hr in this time period).
Patient received a dose of Pfizer today. Patient initially received a Janssen vaccination on 5/4/2021.  Patient not having any adverse reaction at this time.
Patient brought to the ED with generalized weakness worsening over prior 2-3 days, states she started experiencing after receiving 2nd dose of Covid vaccine.  Found to have a positive troponin, hyponatremia.  Stress test revealed reversible myocardial ischemia of the inferior and lateral walls of left ventricle with a large defect size but mild defect severity.  Patient underwent PCI with DES placement and was placed on triple therapy with aspirin, clopidogrel and eliquis.    Patient presented to ED again on 5/23/21 outcome: patient is brought to ED after a fall and loss of unconsciousness, hit her head with large laceration at back of head, 2 episodes of vomiting, leading to  terminal events:  brainstem compression and rapid deterioration and CS of 2T preclude meaningful survival
Stomach Problems; 12 Year Old Received Heplisav-B; Initial Report Received on 05-Jul-2023  A registered pharmacist reported that a 12-year-old male patient (race and ethnicity unknown) received the first dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization and the patient developed stomach problems.   Medical history and concomitant medications at the time of vaccination were not reported.   On 09-Aug-2022, the patient received the first dose of HEPLISAV-B vaccine (Lot # 937233; expiration date 11-Mar-2023; NDC # 43528-003-05) intramuscularly in the left arm (deltoid) from a pharmacist.   On an unspecified date in Sep-2022, after having been vaccinated with HEPLISAV-B, the patient experienced stomach problems.   The reporter confirmed that the event was discovered since the patient was going for his second injection of HEPLISAV-B.  The patient's parent was notified. No adverse reactions were reported. The reporting pharmacist was not aware of the patient experiencing stomach problems in Sep-2022. No additional information was provided.  Company Comment:  The  company assessed the event as non-serious.; Sender's Comments: The company assessed the events as non-serious.